Skip to main content

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Cytarabine

Drug name(s)

Cytosar-U® Cytosine arabinoside Ara-C Cytarabine Liposomal cytarabine DepoCyt®

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Myeloid Leukemia (CML)
  • Lymphoma

Dacarbazine

Drug name(s)

DTIC-Dome® Dacarbazine

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)

Daratumumab

Drug name(s)

Darzalex® Daratumumab

Approved for

  • Myeloma

Daratumumab and hyaluronidase-fihj

Drug name(s)

Darzalex Faspro® Daratumumab and hyaluronidase-fihj

Approved for

  • Myeloma
  • Myeloma-related Amyloidosis

Darbepoetin alfa

Drug name(s)

Aranesp® Darbepoetin alfa

Approved for

  • Other Blood Cancers

Dasatinib

Drug name(s)

Sprycel® Phyrago® Dasatinib

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Myeloid Leukemia (CML)

Daunorubicin

Drug name(s)

Cerubidine® Daunorubicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Daunorubicin and cytarabine

Drug name(s)

Vyxeos® Daunorubicin and cytarabine

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Decitabine

Drug name(s)

Dacogen® Decitabine

Approved for

  • Leukemia
  • Chronic Myelomonocytic Leukemia (CMML)
  • Myelodysplastic Syndromes (MDS)

Decitabine and cedazuridine

Drug name(s)

Inqovi® Decitabine and cedazuridine

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Myelodysplastic Syndromes (MDS)

Deferasirox

Drug name(s)

Exjade® Jadenu® Deferasirox

Approved for

  • Other Blood Cancers

Deferoxamine mesylate

Drug name(s)

Desferal® DFO Deferoxamine mesylate

Approved for

  • Other Blood Cancers

Defibrotide sodium

Drug name(s)

Defitelio® Defibrotide sodium

Approved for

  • Other Blood Cancers

Denileukin diftitox-cxdl

Drug name(s)

Denileukin diftitox-cxdl Lymphir™

Approved for

  • Non-Hodgkin Lymphoma (NHL)

Denosumab

Drug name(s)

Xgeva® Denosumab

Approved for

  • Myeloma

Dexamethasone

Drug name(s)

Prednisone Decadron® Medrol® Methylprednisolone Dexamethasone

Approved for

  • Other Blood Cancers

Doxorubicin

Drug name(s)

Adriamycin® Doxorubicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)

Eflapegrastim-xnst

Drug name(s)

Rolvedon™ Eflapegrastim-xnst

Approved for

  • Other Blood Cancers

Elotuzumab

Drug name(s)

Empliciti™ Elotuzumab

Approved for

  • Myeloma

Elranatamab-bcmm

Drug name(s)

Elranatamab-bcmm

Approved for

  • Myeloma

Enasidenib

Drug name(s)

Idhifa® Enasidenib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Epcoritamab-bysp

Drug name(s)

Epcoritamab-bysp Epkinly®

Approved for

  • Large B-Cell Lymphoma (LBCL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Diffuse Large B-cell Lymphoma (DLBCL) 
  • Follicular Lymphoma (FL) 

Epoetin alfa

Drug name(s)

Epogen® Procrit® EPO Epoetin alfa Epoetin alfa-epbx* Retacrit™ *

Approved for

  • Other Blood Cancers

Etoposide

Drug name(s)

Etopophos® Toposar® VePesid® VP-16 Etoposide

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)

Fedratinib

Drug name(s)

Inrebic® Fedratinib

Approved for

  • Essential Thrombocythemia
  • Primary Myelofibrosis
  • Polycythemia Vera

Filgrastim

Drug name(s)

Neupogen® Filgrastim G-CSF Zarxio™ * Filgrastim-sndz* Nivestym™ * Filgrastim-aafi* Releuko* Filgrastim-ayow*

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Other Blood Cancers

Filgrastim-sndz

Drug name(s)

Zarxio® Filgrastim-sndz

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Other Blood Cancers

Fludarabine

Drug name(s)

Fludara® Fludarabine

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)

Gemtuzumab ozogamicin

Drug name(s)

Mylotarg® Gemtuzumab ozogamicin

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Gilteritinib

Drug name(s)

Xospata® Gilteritinib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Glasdegib

Drug name(s)

Daurismo® Glasdegib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Glofitamab-gxbm

Drug name(s)

Glofitamab-gxbm Columvi™

Approved for

  • Large B-Cell Lymphoma (LBCL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Diffuse Large B-cell Lymphoma (DLBCL) 

Hydroxyurea

Drug name(s)

Droxia® Hydrea® Hydroxyurea

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Essential Thrombocythemia
  • Polycythemia Vera

Ibritumomab tiuxetan

Drug name(s)

Zevalin® Ibritumomab tiuxetan

Approved for

  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)

Ibrutinib

Drug name(s)

Imbruvica® Ibrutinib

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Waldenström Macroglobulinemia (WM)
  • Other Blood Cancers

Idarubicin

Drug name(s)

Idamycin® Idarubicin

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Idecabtagene vicleucel

Drug name(s)

Abecma® Idecabtagene vicleucel

Approved for

  • Myeloma

Idelalisib

Drug name(s)

Zydelig® Idelalisib

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)

Ifosfamide

Drug name(s)

Ifex® Ifosfamide

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)

Imatinib mesylate

Drug name(s)

Gleevec® Imatinib mesylate

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Chronic Eosinophilic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Other Blood Cancers

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.